Methodology Issues in a Tailored Light Treatment for Persons With Dementia

Completed · Not applicable

Conditions studied: Sleep Disturbances, Depression

In brief

Tailored light treatment will increase sleep efficiency, reduce depression and reduce agitation scores in those with Alzheimer's disease and related dementia

Key facts

Study ID

NCT01816152

Run by

Icahn School of Medicine at Mount Sinai

People needed

44

Starts

2020-01-01

Expected to finish

2024-05-10

Last updated by the study team

2026-07-27

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• mild to moderate Alzheimer's disease and related dementia (ADRD)

You may not qualify if…

• major organ failure,
• major illness,
• history of head injury,
• hypertension or diabetes,
• use psychotropic (sleep aid) medicine, obstructing cataracts, macular degeneration, and blindness

Where it is running

• Icahn School of Medicine at Mount Sinai — Albany, New York, United States
• Icahn School of Medicine at Mount Sinai — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.